See also: GLP-1 Guides | Peptide Guides Written by James Whitfield, CSCS , Exercise Physiologist & Performance Researcher Medically reviewed by FormBlends Clinical Review , Clinical Pharmacist & Medical Reviewer Published: Key Takeaway Compare BPC-157 and GHK-Cu peptides: healing mechanisms, clinical efficacy, side effects, and costs
Current medications: interactions are a provider-level assessment, not something a chart can capture
AOD-9604 is not currently on the FDAs compounding restriction list, but MOTS-c is
This peptide has drawn significant interest for its potential therapeutic effects, notably its ability to accelerate the healing of various types of tissues including musculoskeletal and tendon tissues
Step 2 FDA Review of Recommendations: The FDA considers the panel's conclusions alongside internal review